You already have an account? Log In

Why Colorectal Cancer Is Rising in Younger Adults — and What You Can Do

Posted on 26.05.2026

For decades, bowel cancer was framed as something that happened to your grandparents. Screening programs started at 50. Public health campaigns showed older Australians, not twenty-somethings. That picture is now out of date — and the data forcing the rewrite has been piling up for years.

Researchers in Australia, the United States and across Europe are tracking a steady rise in early-onset colorectal cancer: cases diagnosed before the age of 50. The shift is significant enough that screening guidelines have already moved, and oncologists are urging younger adults — and the GPs who see them — to take symptoms seriously rather than dismissing them as stress, haemorrhoids or a dodgy curry.

What the trend actually shows

The pattern isn't a one-country anomaly. Yale Medicine notes that colorectal cancer is now being diagnosed at rising rates among millennials and Gen Z, prompting US authorities to lower the recommended starting age for routine screening from 50 to 45. Australian researchers are seeing a parallel curve. The University of Sydney has flagged that bowel cancer rates among younger people have been climbing for years, even as overall rates in older adults have plateaued or fallen thanks to screening.

The Sydney Morning Herald has profiled cases like Nathan — a young Australian diagnosed with a disease his GP could easily have written off as something benign. His story is becoming familiar: vague abdominal symptoms, a slow path to diagnosis, and a tumour at a stage no one expects in someone barely out of university.

What makes the rise so puzzling is that it crosses national borders, dietary patterns and healthcare systems. Whatever is driving it isn't local.

The risk factors researchers are zeroing in on

There's no single smoking gun, but several threads recur across the research. ScienceAlert, summarising recent work on early-onset disease, points to a cluster of modifiable factors that show up repeatedly: diet, body weight, alcohol, smoking and physical inactivity. The University of Sydney's coverage echoes this, noting that younger people can meaningfully reduce their risk by addressing lifestyle drivers — even if family history and genetics aren't on their side.

Ultra-processed food and red/processed meat. Diets heavy in processed meats and low in fibre have long been linked to colorectal cancer. The generations now being diagnosed grew up with these foods normalised in a way their grandparents didn't.
Obesity and metabolic health. Rising rates of overweight and obesity in younger cohorts parallel — though don't fully explain — the cancer trend.
Alcohol. Even moderate drinking contributes to bowel cancer risk, a point Australian researchers have been blunt about.
Sedentary lifestyles. Regular physical activity appears protective; long hours of sitting do the opposite.
The gut microbiome. Scientists increasingly suspect that early-life antibiotics, diet and other exposures may be reshaping the gut bacterial environment in ways that prime the colon for disease decades later. It's a live area of research rather than settled science.

Importantly, none of these factors fully accounts for the scale of the increase. As researchers quoted across the coverage stress, a young person who eats well, exercises and doesn't drink can still be diagnosed. Lifestyle reduces risk; it doesn't eliminate it.

Why young patients keep getting diagnosed late

One of the most frustrating threads running through patient stories — including the SMH's profile of Nathan — is delayed diagnosis. Younger adults with bowel symptoms often face a longer road to a colonoscopy than older patients with the same complaints.

Part of this is statistical reasoning by clinicians: bowel cancer has historically been rare under 50, so GPs are trained to consider more common explanations first. Part of it is patient hesitation — embarrassment about discussing bowel habits, or a tendency to attribute blood in the stool to haemorrhoids. And part of it is structural: in Australia, the National Bowel Cancer Screening Program currently sends free testing kits to people from age 50 (with eligibility recently extended down to 45 on request), which means symptomatic younger people rely on their GP to flag concerns.

The symptoms worth taking seriously, regardless of age, are consistent across the sources: blood in the stool, persistent changes in bowel habits, unexplained abdominal pain, unintentional weight loss and ongoing fatigue. Iron-deficiency anaemia in a young adult — particularly a young man — should also prompt investigation. None of these symptoms means cancer. But none of them should be brushed off for months either.

The screening shift — and what it means in Australia

The most concrete policy response so far has been to lower the screening age. The US has dropped its recommended start age from 50 to 45, a change Yale Medicine highlights as a direct response to rising early-onset rates. Australia followed, with the National Bowel Cancer Screening Program now offering free immunochemical faecal occult blood test (iFOBT) kits to eligible people from 45.

That matters because the iFOBT is one of the most cost-effective cancer screening tools available — a kit posted to your door, completed at home and returned in a reply-paid envelope. A positive result triggers a colonoscopy, which can detect and remove polyps before they ever become cancer.

For Australians under 45, screening isn't automatic, which is why family history conversations matter. If a parent or sibling has had bowel cancer or significant polyps, you may qualify for earlier and more frequent surveillance through your GP. Conditions like Lynch syndrome and familial adenomatous polyposis dramatically raise risk and warrant specialist input.

Reasons not to despair

The SMH piece on Nathan carried a striking phrase from clinicians: there are "exquisite" reasons not to despair. That isn't spin. Several things are genuinely working in younger patients' favour.

First, when caught early, colorectal cancer is one of the most treatable solid tumours. Five-year survival for localised disease is high, and surgical and oncological techniques have improved markedly.

Second, the field is moving quickly. Researchers are mapping the molecular profile of early-onset tumours, which appear in some ways biologically distinct from those in older patients. That work is opening the door to more targeted treatments and, eventually, better risk-stratification tools that might identify high-risk younger people before symptoms appear.

Third, the awareness campaign is finally landing. GPs are increasingly alert to red-flag symptoms in younger adults. Public conversation — driven in part by high-profile patient stories — is reducing the embarrassment factor that has kept people from raising bowel concerns at all.

What to actually do

The practical takeaways from the research are unglamorous but consistent:

Take symptoms seriously. Blood in the stool or a persistent change in bowel habits warrants a GP visit, not a Google search.
Know your family history and share it with your doctor — it can change your screening eligibility.
Do the iFOBT kit when it arrives. The completion rate in Australia hovers around 40 per cent; doing it is one of the highest-yield health acts available.
Address the modifiable factors: more fibre, less processed meat, less alcohol, more movement, no smoking. These don't guarantee anything, but they shift the odds.

The rise in early-onset colorectal cancer is a real, international trend, and it's worth treating with seriousness rather than fatalism. The science is catching up. The screening systems are adjusting. And the single most powerful tool — paying attention to your own body, and finding a GP who'll do the same — costs nothing.